Results for tag: "Vestibular Schwannoma Drug"

The Vestibular Schwannoma Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat vestibular schwannoma, a type of benign tumor that develops on the vestibulocochlear nerve. These drugs are used to reduce the size of the tumor, reduce symptoms, and improve quality of life. Common treatments include radiation therapy, surgery, and chemotherapy. The Vestibular Schwannoma Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Novartis, Pfizer, Merck, and Sanofi. Other companies such as Bristol-Myers Squibb, AstraZeneca, and GlaxoSmithKline also offer treatments for vestibular schwannoma. Show Less Read more